HomeInsightsPE

Beta Drugs Ltd PE Ratio

Beta Drugs Ltd PE Ratio

stocks purchased

₹ 1.4 Cr

Volume Transacted

()

stocks purchased

6.4 K

Stocks Traded

()

Last Updated on: Dec 08, 2024

Image

Beta Drugs Ltd

NSE: BETA

PE

58

Last updated on: Dec 06, 2024

Key Highlights

  • The P/E Ratio of Beta Drugs Ltd is 58 as of 06 Dec 24 .
  • The P/E Ratio of Beta Drugs Ltd changed from 11.3 on March 2019 to 32.5 on March 2024 . This represents a CAGR of 19.25% over 6 years.
  • The Latest Trading Price of Beta Drugs Ltd is ₹ 2198 as of 06 Dec 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Beta Drugs Ltd

No data available

Company Fundamentals for Beta Drugs Ltd

No data available

Image

Beta Drugs Ltd

NSE: BETA

Share Price

₹ 2198.1

-44.70 (-1.99%)

stock direction

Last updated on: Dec 06, 2024

Market Price of Beta Drugs Ltd

1M

1Y

3Y

5Y

Monitoring Beta Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
06 Dec 20242198.1
05 Dec 20242242.8
04 Dec 20242240.7
03 Dec 20242242.3
02 Dec 20242200
29 Nov 20242171.85
28 Nov 20242143.45
27 Nov 20242246.6
26 Nov 20242192
25 Nov 20242173.2

SWOT Analysis Of Beta Drugs Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Beta Drugs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Beta Drugs Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Key Valuation Metric of Beta Drugs Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Beta Drugs Ltd

No data available

* All values are in crore

Historical Revenue of Beta Drugs Ltd

No data available

* All values are in crore

Historical EBITDA of Beta Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Beta Drugs Ltd

No data available

* All values are in crore

Historical Dividend Payout of Beta Drugs Ltd

No data available

* All values are in %

About Beta Drugs Ltd

  • Beta Drugs Limited was incorporated as a private limited company with the name 'Beta Drugs Private limited' at Himachal Pradesh on September 21, 2005.
  • Subsequently, the company was converted in to public limited company and the name of the company was changed to 'Beta Drugs Limited' on August 11, 2017 Beta Drugs is a part of Adley Group.
  • Adley Group was founded in the year 1985, by its promoter Vijay Batra, who has more than twenty five years of experience in manufacture of pharmaceutical products in India.
  • The Company is a pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers.
  • The Promoter Vijay Batra, took over the company from Kiran Goyal, Deepak Kumar Prince Bharti and Rohit Bansal in the year 2014.

Beta Drugs Ltd News Hub

News

Beta Drugs schedules AGM

Beta Drugs announced that the 19th Annual General Meeting (AGM) of the company will be hel...

Read more

2024-09-02 00:00:00

News

Beta Drugs to conduct EGM

Beta Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be h...

Read more

2024-10-21 00:00:00

News

Beta Drugs to conduct board meeting

Beta Drugs will hold a meeting of the Board of Directors of the Company on 6 November 2024...

Read more

2024-11-04 00:00:00

News

Beta Drugs schedules EGM

Beta Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be h...

Read more

2024-11-28 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions